A Randomized, Open-label, Single-dose, Replicate Crossover Study to Compare the Pharmacokinetics and Safety in Healthy Adult Volunteers Following Oral Administration of JLP-2002
Latest Information Update: 16 Jun 2021
At a glance
- Drugs Antispasmodics (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 11 Jun 2021 New trial record